




版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Case24-year-old,maleMaincomplaintsRepeatedgrosshematuria
for4yrs
HistoryofPresentIllness:Theptsfoundhisurinearebrown,1dayafterupperrespirationinfection.thegrosshematuriacoulddisappearafterthetreatmentwithantibiotics.thesymptomrepeated1~2timesayear.Case
betweentheepisode,urineanalysis:persistentproteinuriaandhematuria(
Pro+BLD3+)Lab:IgG:576↓,IgA:142,IgE:<28.3C3:111,C4:27.8
BUN:13,Crea:0.6,albumin:3.9DPL:1911mg/day
renalbiopsy:IgAnephropathyWhatisIgAnephropathy?Whatisthereason
ofIgAN?WhyhegetsIgAN?HowtotreatIgAN?Whataboutit'sprognosis?IssueIgANephropathyDefinitionIgAmeansimmunoglobulinA,IgAnephropathy(IgAN)isakidneydisorderthatoccurswhenIgA—aproteinthathelpsthebodyfightinfections—settlesinthekidneys.IgAnephropathy
Firstreportedin1968,alsocalledBerger’sDiseasethecommonestprimaryGNvariable:
incidencearedifferentindifferentcountriesandraces
multiformityinclinicalmanifestation,andprognosisIgAnephropathyFinaldiagnosisisdependedon
ImmunofluorescencemicroscopyofrenalbiopsyGreatestfrequencyinCaucasiansandAsians.DiseaseprevalencemayinpartreflectregionalRenalbiopsypractices.Incidence
★SouthAmerica10%
★
Europe
20%
★
AsiaandPacific30-40%
★
China30%±m(xù)ale>femaleOccuratallagespredominate:olderchildrenandyoungadults,20+~30+y/o:↑thecommoncauseofCRFEtiologyMostcasesareidiopathicSLE,Sch?nlein-Henoch
SyndromLivercirrhosis.Glutenenteropathy(非熱帶性口炎性腹瀉).HIVinfection.Wegener’sgranulomatosistreatedwithimmunosuppressiveagentsandURI(upperrespiratoryinfection).Familial.Dermatitisherpatiformis(皰疹性皮炎)
andseronegativearthritis(血清陰性關(guān)節(jié)炎),
psoriasis
(牛皮癬).Gougerot-Houwesyndrome(干燥綜合征)PathogenesisUnknow:whatcausesIgAdepositstoforminthekidneys
.IgAnephropathymayruninfamiliesorberelatedtorespiratoryinfections.NoconsistenttriggerforthediseasehasbeenfoundAbnormalityofIgAregulationinresponsetoanenvironmentalantigen.PlasmaIgAconcentrationincreasedin50%ofcases.DirectcorrelationtocirculationIgAcomplexesanddiseaseseverity.IncreaseinIgA-specificBandTLymphocytesinresponsetoURI(upperrespiratoryinfection).Decreasedmucosalimmunity.IgAimmunecomplexactivatesalternatecomplementpathwaythuseliminationbymonocyte-macrophagesystemisslowandmorecomplexesareavailabletobedepositedontheglomerularmembrane.AlteredstructureofIgAcomplexesandelectrostaticchargealsoslowstheclearancemechanism.IgA-immunecomplexbindstofibronectinwhichhelpsinclearanceafterbindingwithuteroglobin.Abnormaluteroglobinorimpairedproductionpreventsclearance.PathologyLightmicroscopyfindingfocalordiffusemesangialproliferationandmatrixexpansion.Minorglomerularchang(20%),FSGS(28%),mesangialproliferativenephritis(50%),focalsegmentalglomerulonephritis,necrotizingglomerulonephritis,mesangiocapillary
glomerulonephritis,crescentic
glomerulonephritis,GlobulardepositsofIgA(alongwithC3andIgG)asdemonstratedbyImmunofluorescencemicroscopyinthemesangiumandglomerularcapillarywall.Electronmicroscopyshowingelectrondensedepositsofmesangium.Mesangialelectrondensedepositswith↑mesangialmatrix&cellularityinIgANClinicalPresentationClinicalfeature:1.predilectioninyoungmen:
predominate:13~15yr2.
manyptswithforerunnerinfectionbeforeepisodeorrelapse3.
hematuriaisverycommon一、hematuria:infectionortired40to50%presentwithrecurrentgrosshematuria.30to50%withmicroscopichematuriaandprotienuria.20to25%progresstogrosshematuria.二、proteinuriawithorwithoutmicroscopichematuria
thecommonestclinicalfeature(>50%)三、nephroticsyndrome
about3~4%,
areportinChina16.7%
四、Hypertension
AdultIgA>50%,children
5%。
about6yrsbeforerenalfailure。somepatientsmalignanthypertension五、Chronicrenalfailure10~20yrsafterdignosis,someptsatthefirstvisit。六、Acuterenalfailure(<10%)
1.ATN:RBCblockkidneytubules
2.Acutenephriticsyndrome,transientRF,pathologyissameasAGN3.Rapidlyprogressiveglomerulonephritis,
RPGN,progressiverenalfunctiondeteriorationFiveClinicalsyndromes1.Grosshematuria2.Asymptomaticmicroscopichematuriawith/withoutproteinuria----62%3.Acutenephritiswithhypertensionand/orrenalinsufficiency4.Nephroticsyndrome5.Amixednephritic-nephroticsyndromeLaboratoryexaminationUA:hematuria,proteinuriaserumIgA
↑(30~70%,China10~30%)
IgG,IgMarenormal,C3,CH50arenormalorslightly↑IgA-FN↑,IgA-IC↑someptswithHBsAgpositive
Diagnosisimmunohistochemicalfindingsof
mesangialdepositionofIgAlightmicroscopy:mesangialcell
proliferationisthecommonestfeatureDifferentialdiagnosis
1.post-streptococcalGN(AGN)latentperiodof10-21daysaffectchildrenprincipally,
hematuriaprincipally,hypertensiontransientrenalinsufficiencyCH50andC3lowbutnormalisesafter6-8weeks
2.chronicGN(non-IgA)
3.hereditaryGN
4.secondaryIgAN
Henoch-Sch?nleinpurpuraLupusnephritisHenoch-Sch?nleinpurpuraHenoch-Sch?nleinpurpura(HSP)HSP:clinicalsyndromeSame:histopathologicalalterationsDifference:HSPhassystemicsymptoms:purpuricrash,arthralgias,abdominalpain,acuteonset,self-limited.VariantsofthesamepathophysiologicprocessTreatmentGoal:preventprogressionofdiseaseandprotectrenalfunctionaccordingtotheclinicalfeatureandpathologictype
ACEInhibitorsCorticosteroidsImmunosuppressantsFish-oilsupplementTonsillectomy1、Hematuriaormildproteinuria
Forpatientswithnormalrenalfunction,
normotensionandonlyminorurinary
abnormalities,suchasisolatedmicroscopic
haematuria,and/ormildproteinuria,thegeneral
consensusisnottoofferspecifictreatmentbutto
keepsuchpatientsunderreview.
Upto23%ofpatientswillhaveaspontaneous
completeremission.TonsillectomyIgA:mucosadefensePopularinJapanandFrance.Indication:chronicinfections(dentalabscess,sinusitis)Inpediatric:tonsillectomy:↓grosshematuriaepisodes.NoevidenceforaffecttheprogressiontoCRIorESRD.Recommended:controversial2、massproteinuriaorNS3、Rapidlyprogressiveglomerulonephritis,RPGN
4、Chronicglomerulonephritistreattheinfectionantiplateletadhesiveness、anticoagulationeicosapentaenoicacid(一種魚油,3-ω脂肪酸):postponeprogressofrenalfibrinolyticagent——urokinase,reduceth
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 貧血的診治及護(hù)理
- 小學(xué)生社交課件下載網(wǎng)站
- 2025至2030年中國(guó)帶狀式光纜數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 幼兒歌曲伴奏MUSIC78課件
- 2025至2030年中國(guó)塑料木工推把數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 2025至2030年中國(guó)亞克力梅花棒數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 2025年度車庫(kù)停車費(fèi)調(diào)整與收費(fèi)標(biāo)準(zhǔn)協(xié)議書
- 2025年度水利水電工程施工安全生產(chǎn)監(jiān)理合同
- 2025年度旅游產(chǎn)品提供商游客免責(zé)協(xié)議范本
- (高清版)DZT 0145-2017 土壤地球化學(xué)測(cè)量規(guī)程
- 供熱公司安全教育知識(shí)
- 高中英語(yǔ)課程綱要
- 《藥物設(shè)計(jì)學(xué)》課件
- 隨機(jī)微分方程
- 道路設(shè)施施工現(xiàn)場(chǎng)安全管理基本要求
- 公寓樓改造裝修施工方案
- 煙臺(tái)大學(xué)化學(xué)化工學(xué)院實(shí)驗(yàn)室儀器設(shè)備搬遷項(xiàng)目
- 安全生產(chǎn)管理組織架構(gòu)圖
- 2022版10kV架空配電線路無(wú)人機(jī)自主巡檢作業(yè)導(dǎo)則
- 近二十年俄羅斯修辭學(xué)研究述評(píng)
評(píng)論
0/150
提交評(píng)論